Drugs / House Dust Mite Allergen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05019209 | Sep 2021 → Feb 2022 | atopic eczema, house allergic alveolitis | Fraunhofer-Institute of Toxicology and Experimental Medicine | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | House Dust Mite Allergen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05019209 ↗ |